UAB "Caerus Biotechnologies" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,110,464 |
352,528 |
226,238 |
-226,238 |
-71,822 |
46.16 |
-20.37 |
-233,141 |
1,069,278 |
233,254 |
662,738 |
2023 |
---|
1,116,963 |
450,388 |
22,784 |
20,628 |
8,318 |
66.80 |
1.85 |
-212,513 |
1,245,813 |
109,111 |
946,558 |
2024 |
---|
1,039,193 |
346,398 |
66,823 |
63,419 |
21,140 |
70.09 |
6.10 |
-149,094 |
1,319,331 |
11,723 |
1,163,221 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
1,039,193 €-7 % *
Sales per employee (€)
346,398 €-23 % *
Profit before tax (€)
66,823 €193 % *
Net Profit (€)
63,419 €207 % *
Profit per employee (€)
21,140 €154 % *
Total profitability (%)
70.09 %4.93 % *
Net profitability (%)
6.10 %229.73 % *
Equity (€)
-149,094 €30 % *
Amounts Payable And Liabilities (€)
1,319,331 €6 % *
Non-current Assets (€)
11,723 €-89 % *
CurrentAssets (€)
1,163,221 €23 % *